Zhang Zhiyi, Huang Cibo, Jiang Quan, Zheng Yi, Liu Yi, Liu Shengyun, Chen Yingjuan, Mei Yifang, Ding Changhai, Chen Min, Gu Xin, Xing Dan, Gao Min, He Lan, Ye Zhizhong, Wu Lijun, Xu Jianhua, Yang Pinting, Zhang Xuewu, Zhang Yue, Chen Jinwei, Lin Jin, Zhao Like, Li Mengtao, Yang Wanling, Zhou Yixin, Jiang Qing, Chu Cong-Qiu, Chen Yaolong, Zhang Weiya, Tsai Wei-Chung, Lei Guanghua, He Dongyi, Liu Wei, Fang Yongfei, Wu Darong, Lin Jianhao, Wei Cheng-Chung, Lin Hsiao-Yi, Zeng Xiaofeng
Department of Rheumatology and Immunology, the First Affiliated Hospital of Harbin Medical University, Harbin, China.
Department of Rheumatology and Immunology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China.
Ann Transl Med. 2020 Oct;8(19):1213. doi: 10.21037/atm-20-4665.
Osteoarthritis (OA) is a degenerative disease of middle-aged and elderly people, contributed a higher burden of disease in China and the world. In 2017, under the support of the Rheumatology and Immunology Expert Committee of the Cross-Strait Medical and Health Exchange Association. The objective was to develop an evidence-based diagnosis and treatment guideline for OA in China based on emerging new evidence. The guideline was registered at International Practice Guidelines Registry Platform (IPGRP-2018CN028). The grading of recommendations assessment, development and evaluation (GRADE) approach was used to rate the quality of evidence and the strength of recommendations, and the RIGHT (Reporting Items for Practice Guidelines in Healthcare) checklist was followed to report the guideline. The guideline provides recommendations for the OA diagnosis, disease risks monitoring and evaluate, treatment purpose and physical, medical and surgical interventions. This guideline is intended to serve as a tool for Chinese clinicians for the best decisions-making on diagnosis and treatment of OA.
骨关节炎（OA）是一种中老年人的退行性疾病，在中国和全球造成了较高的疾病负担。2017年，在海峡两岸医疗卫生交流协会风湿免疫专家委员会的支持下，旨在基于新出现的证据制定中国OA的循证诊断和治疗指南。该指南在国际实践指南注册平台（IPGRP-2018CN028）注册。采用推荐意见评估、制定与评价（GRADE）方法对证据质量和推荐强度进行评级，并遵循医疗卫生实践指南报告条目（RIGHT）清单报告该指南。该指南为OA诊断、疾病风险监测与评估、治疗目的以及物理、药物和手术干预提供了推荐意见。本指南旨在作为中国临床医生对OA诊断和治疗做出最佳决策的工具。
